Drug Type Small molecule drug |
Synonyms Aurisuppostoria Chloramphenicoli, Chloramphenicol (JP17/USP/INN), Chloramphenicol Ear Pills + [30] |
Target |
Mechanism 50S subunit inhibitors(50S ribosomal subunit inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date CA (01 Jan 1951), |
Regulation- |
Molecular FormulaC11H12Cl2N2O5 |
InChIKeyWIIZWVCIJKGZOK-RKDXNWHRSA-N |
CAS Registry56-75-7 |
Start Date20 May 2021 |
Sponsor / Collaborator- |
Start Date15 Nov 2020 |
Sponsor / Collaborator |
Start Date02 Oct 2019 |
Sponsor / Collaborator- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Conjunctivitis, Bacterial | GB | 13 Dec 1984 | |
Bacterial Vaginosis | JP | 17 Apr 1981 | |
Bacterial Infections | CA | 01 Jan 1951 |
Study | Phase | Population | Analyzed Enrollment | Group | Results | Evaluation | Publication Date |
---|
Not Applicable | - | - | Ziclor P gel | jtwrlrpwsy(lxjjlqdrkj) = ATP levels were significantly (p<0.05) reduced by the three formulations exposure compared to the new gel Ziclor P edsylyisnq (pmufrpktdu ) View more | - | 01 May 2022 | |
Ducressa eye-drops | |||||||
Not Applicable | - | 972 | nnyuotqadn(bhlojevpjc) = natdpkjrhn vqrhxnwzny (srxzggbifh, 4.9 - 8.8) | Positive | 15 Jan 2009 | ||
nnyuotqadn(bhlojevpjc) = fztefltwxo vqrhxnwzny (srxzggbifh, 7.9 - 15.1) | |||||||
Not Applicable | - | xwnzvhqvec(mdoirvstgc) = aqgvpknoio caofhynkyq (ssluaeaoud ) | - | 12 Jan 2008 | |||
xwnzvhqvec(mdoirvstgc) = qpbuipmhdi caofhynkyq (ssluaeaoud ) |